emilie.sbidian@aphp.fr Funding sources : none Conflict of interest statement ,
Hidradenitis Suppurativa, New England Journal of Medicine, vol.366, issue.2, pp.158-64, 2012. ,
DOI : 10.1056/NEJMcp1014163
Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies, Journal of the American Academy of Dermatology, vol.59, issue.4, pp.596-601, 2008. ,
DOI : 10.1016/j.jaad.2008.06.020
European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa, Journal of the European Academy of Dermatology and Venereology, vol.36, issue.Suppl. 1, 2015. ,
DOI : 10.1111/jdv.12966
A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa, British Journal of Dermatology, vol.121, issue.2, pp.391-399, 2011. ,
DOI : 10.1111/j.1365-2133.2011.10339.x
Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa, Annals of Internal Medicine, vol.157, issue.12, pp.846-55, 2012. ,
DOI : 10.7326/0003-4819-157-12-201212180-00004
A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa, J Drugs Dermatol, vol.11, pp.15-20, 2012. ,
Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial, Journal of the American Academy of Dermatology, vol.62, issue.2, pp.205-222, 2010. ,
DOI : 10.1016/j.jaad.2009.06.050
Treatment of Hidradenitis Suppurativa With Etanercept Injection, Archives of Dermatology, vol.146, issue.5, pp.501-505, 2010. ,
DOI : 10.1001/archdermatol.2010.72
Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study, Journal of Investigative Dermatology, vol.133, issue.6, pp.1506-1517, 2013. ,
DOI : 10.1038/jid.2012.472
Use of biological treatments in patients with hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology, vol.24, issue.Suppl 2, pp.56-60, 2015. ,
DOI : 10.1111/jdv.12438
Predictors of response to anti-TNF-?? therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, vol.45, issue.12, pp.1558-65, 2006. ,
DOI : 10.1093/rheumatology/kel149
Bastuji-Garin S Smoking and hidradenitis suppurativa: risk or pronostic factor ? Results from a series of 947 patients, J Invest Dermatol, vol.132, pp.70-74, 2012. ,
Risk factors for ulcerative colitis: A population-based, case???control study in Spain, Journal of Crohn's and Colitis, vol.2, issue.2, pp.158-61, 2008. ,
DOI : 10.1016/j.crohns.2008.01.003
First medicine recommended for approval for hidradenitis suppurativa. On september, 2015. ,